Eloxx Pharmaceuticals, Inc. (ELOX) vs NOMAD Power Solutions, Inc. (NMAD)

A side-by-side comparison of Eloxx Pharmaceuticals, Inc. and NOMAD Power Solutions, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ELOX

Eloxx Pharmaceuticals, Inc.

$50M

$14.68HealthcareDelayed quote: Oct 6, 2026, 1:14 PM EDT

NMAD

NOMAD Power Solutions, Inc.

$52M

$4.19HealthcareDelayed quote: Oct 6, 2026, 1:27 PM EDT

Total return — ELOX vs NMAD

growth of $100 · dividends reinvested · last 1y

ELOX +40.0% (+40.0%/yr)NMAD -41.6% (-41.6%/yr)ELOX compounded faster over this window

ELOX NMAD

Metrics side by side

ELOX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ELOX analysis Full NMAD analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.